Prosight Management’s KalVista Pharmaceuticals KALV Stock Holding History

Prosight Management’s Portfolio KALV Stock Details KALV Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell
2023 Q1	$1.89M	Sell
2022 Q4	$4.2M	Buy
2022 Q3	$7.69M	Sell
2022 Q2	$8.08M	Buy
2022 Q1	$8.69M	Buy
2021 Q4	$5.42M	Buy
2021 Q3	$4.49M	Buy
2021 Q2	$4.34M	Buy